Hippocratic AI, a healthcare AI startup focused on patient-facing, non-diagnostic tasks, has raised $141 million in a Series B funding round led by Kleiner Perkins, bringing its valuation to $1.64 billion. This funding, announced just nine months after a $53 million Series A round backed by General Catalyst and Andreessen Horowitz, and five months after a $17 million investment from NVIDIA, underscores the rapid growth of the less-than-two-year-old company. Unlike many healthcare AI companies that target administrative efficiency, Hippocratic AI focuses on addressing the healthcare workforce shortage by creating AI agents capable of handling tasks like pre-operative procedures, remote monitoring, and appointment preparation.
With contracts signed with 23 health systems and insurers in 2024, Hippocratic AI plans to use the new capital to expand its product offerings into more markets and internationally. The company’s AI agents aim to fill gaps in patient care by performing simple, scalable tasks, freeing up healthcare professionals to focus on complex, direct care. This latest funding solidifies Hippocratic AI’s position as a leader in leveraging generative AI to tackle healthcare challenges on a global scale.